Neuropsychiatric Symptoms of Epilepsy

14 Dementia
253
145. Ford AH, Flicker L, Alfonso H, Thomas J, Clarnette R, Martins R, et al. Vitamins B(12),
B(6), and folic acid for cognition in older men. Neurology. 2010;75:1540–7. doi: 10.1212/
wnl.0b013e3181f962c4 .
146. Blasko I, Hinterberger M, Kemmler G, Jungwirth S, Krampla W, Leitha T, Heinz Tragl K,
Fischer P. Conversion from mild cognitive impairment to dementia: influence of folic acid
and vitamin B12 use in the VITA cohort. J Nutr Health Aging. 2012;16:687–94. doi: 10.1007/
s12603-012-0051-y .
147. Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson’s disease: progress and therapeutic
implications. Mov Disord. 2013;28:14–23. doi: 10.1002/mds.25249 .
148. Morrell MJ, Sarto GE, Shafer PO, Borda EA, Herzog A, Callanan M. Health issues for
women with epilepsy: a descriptive survey to assess knowledge and awareness among healthcare
providers. J Womens Health Gend Based Med. 2000;9:959–65.
doi: 10.1089/15246090050199982 .
149. Hernández R, Fernández Mde L, Miranda G, Suástegui R. Decrease of folic acid and cognitive
alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study.
Rev Invest Clin. 2005;57:522–31.
150. Sener U, Zorlu Y, Karaguzel O, Ozdamar O, Coker I, Topbas M. Effects of common antiepileptic
drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and
vitamin B6. Seizure. 2006;2:79–85. doi: 10.1016/j.seizure.2005.11.002 .
151. Ogawa Y, Kaneko S, Otani K, Fukushima Y. Serum folic acid levels in epileptic mothers and
their relationship to congenital malformations. Epilepsy Res. 1991;8:75–8.
doi: 10.1016/0920-1211(91)90039-i .
152. Yoshiike Y, Kimura T, Yamashita S, Furudate H, Mizoroki T, Murayama M, et al. GABAA
receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its
pharmacological treatment by picrotoxin. PLoS One. 2008;3:3029. doi: 10.1371/journal.
pone.0003029 .
153. Kuruba R, Hattiangady B, Shetty AK. Hippocampal neurogenesis and neural stem cells in
temporal lobe epilepsy. Epilepsy Behav. 2009;14 Suppl 1:65–73. doi: 10.1016/j.
yebeh.2008.08.020 .
154. Hattiangady B, Shetty AK. Subcutaneous administration of BDNF dramatically enhances
dentate neurogenesis in the injured aged hippocampus. Soc Neurosci Abstr. 2007;562:12.
155. Jin K, Sun Y, Xie L, Batteur S, Mao XO, Smelick C, et al. Neurogenesis and aging: FGF-2
and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice.
Aging Cell. 2003;2:175–83. doi: 10.1046/j.1474-9728.2003.00046.x .
156. Shetty AK, Hattiangady B. Prospects of stem cell therapy for temporal lobe epilepsy. Stem
Cells. 2007;25:2396–407. doi: 10.1634/stemcells.2007-0313 .
157. Kohl Z, Winner B, Ubhi K, Rockenstein E, Mante M, Münch M, et al. Fluoxetine rescues
impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model. Eur J
Neurosci. 2012;35:10–9. doi: 10.1111/j.1460-9568.2011.07933.x .
158. Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, et al. Sertraline
for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry
Neurol. 2011;24(4):222–8. doi: 10.1177/0891988711422527 .
159. Mula M, Schmitz B, Sander JW. The pharmacological treatment of depression in adults with
epilepsy. Expert Opin Pharmacother. 2008;9:3159–68. doi: 10.1517/14656560802587024 .
160. Pisani F, Spina E, Oteri G. Antidepressant drugs and seizure susceptibility: from in vitro data
to clinical practice. Epilepsia. 1999;40 Suppl 10:S48–56. doi: 10.1111/j.1528-1157.1999.
tb00885.x .
161. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and
management. CNS Drugs. 2002;16:291–302. doi: 10.2165/00023210-200216050-00002 .
162. Sanchez PE, Zhu L, Verret L, Vossel KA, Orr AG, Cirrito JR, et al. Levetiracetam suppresses
neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s
disease model. Proc Natl Acad Sci U S A. 2012;109:2895–903. doi: 10.1073/pnas.1121081109 .